Gilead Sciences Inc. (a company registered in the US State of Delaware) v Nucana Plc

JurisdictionEngland & Wales
JudgeMr Justice Meade
Judgment Date21 March 2023
Neutral Citation[2023] EWHC 611 (Pat)
Docket NumberCase No: HP-2021-000007
CourtChancery Division (Patents Court)
Year2023
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
2 cases
  • Pfizer Ltd v Glaxosmithkline Biologicals S.A (a company incorporated under the laws of Belgium)
    • United Kingdom
    • Chancery Division (Patents Court)
    • 7 October 2024
    ...some of the approach actually used in Mölnlycke.” 703 I have found valuable the following observations by Meade J in Gilead v NuCana [2023] EWHC 611 (Pat), where he applied the distinction between primary and secondary evidence to an issue of undue burden: ‘442. Where the issue is one of ob......
  • Sandoz AG v Biogen Ma Inc.
    • United Kingdom
    • Chancery Division (Patents Court)
    • 11 October 2024
    ...Mentor Corp v. Hollister Inc.” 319 The role of secondary evidence concerning insufficiency was discussed by Meade J in Gilead v NuCana [2023] EWHC 611 at [442]–[446], where he acknowledged its potential usefulness in giving “the possibility of a real-world cross-check on what the experts sa......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT